Metraipolis › archive › dc_a1e87c9fcdba

Phase Ib study of enzalutamide with venetoclax in patients with metastatic castration-resistant prostate cancer — Europe PMC PMID:41315064

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41315064
DOI
10.1007/s00280-[numero omesso]-2
License (as archived)
solo-consultazione
Archived
2026-11-08T04:07:06.567Z
SHA-256 of the archived text
5b9603363381febd586600559a075377e1b711d56d230588dc0630ece07b867d
Stable URL of this page
https://metraipolis.com/documento/dc_a1e87c9fcdba

How to cite

Phase Ib study of enzalutamide with venetoclax in patients with metastatic castration-resistant prostate cancer — Europe PMC PMID:41315064 — Europe PMC (en), https://europepmc.org/article/MED/41315064 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a1e87c9fcdba (Metraipolis archive dc_a1e87c9fcdba, sha256 5b9603363381febd586600559a075377e1b711d56d230588dc0630ece07b867d)
BibTeX
@misc{dca1e87c9fcdba,
  title = {Phase Ib study of enzalutamide with venetoclax in patients with metastatic castration-resistant prostate cancer — Europe PMC PMID:41315064},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41315064},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a1e87c9fcdba; sha256 5b9603363381febd586600559a075377e1b711d56d230588dc0630ece07b867d},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41315064. Agents can read the archived copy with the MCP tool read_document.